Evidence map›Paper›PMID 23029216›Full record

ArticlePloS one2012

Rhomboids of Mycobacteria: characterization using an aarA mutant of Providencia stuartii and gene deletion in Mycobacterium smegmatis.

David Patrick Kateete, Fred Ashaba Katabazi, Alfred Okeng, Moses Okee, Conrad Musinguzi, Benon Byamugisha Asiimwe, Samuel Kyobe, Jeniffer Asiimwe, W Henry Boom, Moses Lutaakome Joloba

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Microorganisms · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

David Patrick KateeteDepartment of Medical Microbiology, School of Biomedical Sciences, Makerere University College of Health Sciences (MakCHS), Kampala, Uganda.
Fred Ashaba Katabazi
Alfred Okeng
Moses Okee
Conrad Musinguzi
Benon Byamugisha Asiimwe
Samuel Kyobe
Jeniffer Asiimwe
W Henry Boom
Moses Lutaakome Joloba
Makerere University · UGCase Western Reserve University · US

Funding

Tuberculosis Prevention Research Unit /TBRU/-266095383N01AI095383 · NIAID · CASE WESTERN RESERVE UNIVERSITY · 2000 to 2005
$5.6M
UGANDA HIV/TB COHRE TRAiNING PROGRAMU2RTW006879 · FIC · JOINT CLINICAL RESEARCH CENTER · PI MUGYENYI, PETER N · 2004 to 2013
$3.6M
CELL TO CELL SIGNALING IN MYCOBACTERIAR01AI075637 · NIAID · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI JOLOBA, MOSES LUTAAKOME · 2007 to 2010
$319k
ROLE OF RHOMBOID HOMOLOGUES IN MYCOBACTERIA SIGNALINGR03AI062849 · NIAID · MAKERERE MEDICAL SCHOOL · PI JOLOBA, MOSES LUTAAKOME · 2005 to 2006
$107k
FIC NIH HHS U2R TW006879NIAID NIH HHS HHSN266200700022C/N01-AI-70022NIAID NIH HHS N01 AI070022NIAID NIH HHS N01 AI095383NIAID NIH HHS N01-AI-95383NIAID NIH HHS R01 AI075637NIAID NIH HHS R03 AI062849
6 · The paper itself

Abstract

backgroundRhomboids are ubiquitous proteins with unknown roles in mycobacteria. However, bioinformatics suggested putative roles in DNA replication pathways and metabolite transport. Here, mycobacterial rhomboid-encoding genes were characterized; first, using the Providencia stuartii null-rhomboid mutant and then deleted from Mycobacterium smegmatis for additional insight in mycobacteria. METHODOLOGY/PRINCIPAL

findingsUsing in silico analysis we identified in M. tuberculosis genome the genes encoding two putative rhomboid proteins; Rv0110 (referred to as "rhomboid protease 1") and Rv1337 ("rhomboid protease 2"). Genes encoding orthologs of these proteins are widely represented in all mycobacterial species. When transformed into P. stuartii null-rhomboid mutant (ΔaarA), genes encoding mycobacterial orthologs of "rhomboid protease 2" fully restored AarA activity (AarA is the rhomboid protein of P. stuartii). However, most genes encoding mycobacterial "rhomboid protease 1" orthologs did not. Furthermore, upon gene deletion in M. smegmatis, the ΔMSMEG_4904 single mutant (which lost the gene encoding MSMEG_4904, orthologous to Rv1337, "rhomboid protease 2") formed the least biofilms and was also more susceptible to ciprofloxacin and novobiocin, antimicrobials that inhibit DNA gyrase. However, the ΔMSMEG_5036 single mutant (which lost the gene encoding MSMEG_5036, orthologous to Rv0110, "rhomboid protease 1") was not as susceptible. Surprisingly, the double rhomboid mutant ΔMSMEG_4904-ΔMSMEG_5036 (which lost genes encoding both homologs) was also not as susceptible suggesting compensatory effects following deletion of both rhomboid-encoding genes. Indeed, transforming the double mutant with a plasmid encoding MSMEG_5036 produced phenotypes of the ΔMSMEG_4904 single mutant (i.e. susceptibility to ciprofloxacin and novobiocin). CONCLUSIONS/SIGNIFICANCE: Mycobacterial rhomboid-encoding genes exhibit differences in complementing aarA whereby it's only genes encoding "rhomboid protease 2" orthologs that fully restore AarA activity. Additionally, gene deletion data suggests inhibition of DNA gyrase by MSMEG_4904; however, the ameliorated effect in the double mutant suggests occurrence of compensatory mechanisms following deletion of genes encoding both rhomboids.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBiofilmsCiprofloxacinDrug Resistance, BacterialGene Knockout TechniquesGenetic Complementation TestMycobacterium smegmatisNovobiocinPeptide HydrolasesPhenotypeProvidenciaAnti-Bacterial AgentsBacterial ProteinsCiprofloxacinNovobiocinPeptide Hydrolases

Identifiers

PMID23029216
PMCPMC3448690
OpenAlexW2106827145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.